Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportGeneral Clinical Specialties: Endocrinology

When to evaluate the final success rate of thyroid remnant ablation following low dose I-131 administration?

Medvedec Mario
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 147;
Medvedec Mario
1Department of Nuclear Medicine and Radiation Protection, University Hospital Centre Zagreb, Zagreb, Croatia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 51 no. supplement 2 147

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online November 3, 2014.

Copyright & Usage 
© 2010

Author Information

  1. Medvedec Mario1
  1. 1Department of Nuclear Medicine and Radiation Protection, University Hospital Centre Zagreb, Zagreb, Croatia

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: December 2014 to April 2025

AbstractFullPdf
Dec 2014500
Jan 2015700
Apr 2015300
May 2015200
Jun 2015700
Aug 2015100
Sep 2015600
Nov 2015400
Jan 2016200
Feb 2016400
Mar 2016300
Apr 2016100
Nov 2016100
Apr 2017100
Jun 2017200
Aug 2017100
Sep 2017300
Nov 2017500
Dec 2017200
Feb 2018100
Mar 2018300
Apr 2018500
May 2018400
Jun 2018100
Aug 20181300
Sep 2018200
Oct 2018100
Aug 2019100
Oct 2019200
Feb 2020400
Mar 20201300
Apr 2020900
May 2020100
Jul 2020300
Aug 20201200
Sep 20201900
Oct 2020500
Nov 20201200
Dec 2020400
Jan 2021100
Feb 20211100
Mar 2021900
Apr 2021700
May 2021700
Jun 2021300
Jul 20211200
Aug 20212200
Sep 2021500
Oct 2021500
Nov 20213400
Dec 20211900
Jan 20223400
Feb 20221200
Mar 2022600
Apr 20221400
May 20221200
Jun 2022300
Jul 2022100
Aug 2022300
Sep 2022400
Oct 2022100
Nov 2022100
Dec 2022200
Jan 2023200
Feb 2023300
Mar 2023300
Apr 2023100
May 2023200
Jun 2023300
Jul 2023100
Aug 2023400
Sep 2023200
Oct 2023200
Nov 2023200
Dec 2023300
Jan 2024500
Feb 2024400
Mar 2024800
Apr 2024200
May 2024200
Jun 2024400
Jul 2024200
Aug 20241700
Sep 20241500
Oct 2024400
Nov 2024400
Dec 2024300
Jan 2025200
Feb 2025300
Mar 2025300
Apr 20251200
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 51, Issue supplement 2
May 2010
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
When to evaluate the final success rate of thyroid remnant ablation following low dose I-131 administration?
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
When to evaluate the final success rate of thyroid remnant ablation following low dose I-131 administration?
Medvedec Mario
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 147;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
When to evaluate the final success rate of thyroid remnant ablation following low dose I-131 administration?
Medvedec Mario
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 147;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

General Clinical Specialties: Endocrinology

  • A comparison of the psychological status in the patients with hyperthyroidism before and after treatment with radioiodine-131
  • The correlation between salivary gland uptake in pre- and post-ablative 131I whole body scan and late salivary gland side effect after initial radioactive iodine therapy
  • The frequency of vomiting after outpatient I-131 therapy (tx) in patients (pts) with well-differentiated thyroid cancer (WDTC)
Show more General Clinical Specialties: Endocrinology

Endocrinology: Management of Thyroid Cancer in 2010

  • Impact of TNM status on rhTSH-aided I-131 thyroid remnant ablation (rhTSH-A) success in patients (pats) with differentiated thyroid cancer (DTC): Preliminary data from an international, multicenter retrospective study
  • Radioiodine thyroid remnant ablation (RRA) in patients with differentiated thyroid cancer (DTC): Impact of recombinant human thyroid-stimulating hormone (rhTSH) on treatment room length-of-stay and utilization
  • Changes in biochemical parameters in thyroid cancer patients preparing for radioiodine ablation after total thyroidectomy: Thyroxine withdrawal vs. rhTSH injection
Show more Endocrinology: Management of Thyroid Cancer in 2010

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire